Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Lippman

Showing results (151-160 of 340) with videos related to

Pageof 34
Sort By:
American Journal of Clinical Oncology|February 6, 2009
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumorsWilliam N William, Joseph L Lee, Dong M Shin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention TrialIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomasSvetlana Bolshakov, Christopher M Walker, Sara S Strom, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2003
The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cellsImad Shureiqi, Wei Jiang, Xiangsheng Zuo, et al.
Contemporary Clinical Trials|August 20, 2010
Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodologyMatteo Lazzeroni, Aliana Guerrieri-Gonzaga, Davide Serrano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancerLin Wang, Ashraful Hoque, Robert Z Luo, et al.
Journal of the National Cancer Institute|August 17, 2006
Effect of finasteride on the sensitivity of PSA for detecting prostate cancerIan M Thompson, Chen Chi, Donna Pauler Ankerst, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 9, 2009
Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variantsXifeng Wu, Margaret R Spitz, J Jack Lee, et al.
American Journal of Clinical Oncology|August 19, 2009
Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small-cell lung cancer as frontline and second-line therapyWilliam N William, Fadlo R Khuri, Frank V Fossella, et al.
Clinical Lung Cancer|February 4, 2014
Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancerJin-Soo Kim, Edward S Kim, Diane Liu, et al.
Pageof 34

Showing results (151-160 of 340) with videos related to

Sort By:
Pageof 34
American Journal of Clinical Oncology|February 6, 2009
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumorsWilliam N William, Joseph L Lee, Dong M Shin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention TrialIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomasSvetlana Bolshakov, Christopher M Walker, Sara S Strom, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2003
The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cellsImad Shureiqi, Wei Jiang, Xiangsheng Zuo, et al.
Contemporary Clinical Trials|August 20, 2010
Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodologyMatteo Lazzeroni, Aliana Guerrieri-Gonzaga, Davide Serrano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancerLin Wang, Ashraful Hoque, Robert Z Luo, et al.
Journal of the National Cancer Institute|August 17, 2006
Effect of finasteride on the sensitivity of PSA for detecting prostate cancerIan M Thompson, Chen Chi, Donna Pauler Ankerst, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 9, 2009
Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variantsXifeng Wu, Margaret R Spitz, J Jack Lee, et al.
American Journal of Clinical Oncology|August 19, 2009
Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small-cell lung cancer as frontline and second-line therapyWilliam N William, Fadlo R Khuri, Frank V Fossella, et al.
Clinical Lung Cancer|February 4, 2014
Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancerJin-Soo Kim, Edward S Kim, Diane Liu, et al.
Pageof 34